PRAECIS PHARMACEUTICALS INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: PRAECIS PHARMACEUTICALS INC, 10-Q, EX-10.7, 2000-08-14
Next: FIRST INDUSTRIAL LP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         167,931
<SECURITIES>                                         0
<RECEIVABLES>                                    3,460
<ALLOWANCES>                                         0
<INVENTORY>                                     29,957
<CURRENT-ASSETS>                               212,832
<PP&E>                                          11,524
<DEPRECIATION>                                   5,097
<TOTAL-ASSETS>                                 221,439
<CURRENT-LIABILITIES>                           49,631
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           419
<OTHER-SE>                                     169,116
<TOTAL-LIABILITY-AND-EQUITY>                   221,439
<SALES>                                              0
<TOTAL-REVENUES>                                 9,972
<CGS>                                                0
<TOTAL-COSTS>                                   14,172
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (2,052)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,052)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,052)
<EPS-BASIC>                                      (.07)
<EPS-DILUTED>                                    (.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission